Age-Related Changes in Niche Cells Influence Hematopoietic Stem Cell Function  by Oakley, Erin J. & Van Zant, Gary
Cell Stem Cell
PreviewsAge-Related Changes in Niche Cells Influence
Hematopoietic Stem Cell FunctionErin J. Oakley1 and Gary Van Zant1,*
1Department of Internal Medicine and Markey Cancer Center, University of Kentucky, 800 Rose Street, Lexington, KY 40536, USA
*Correspondence: gvzant1@uky.edu
DOI 10.1016/j.stem.2010.01.008
Ina recent issueofNature,Mayacketal. (2010)useyoungandoldparabioticmice toshowthat systemicsignals
from the young parabiont rejuvenate hematopoietic stem cell function via the microenvironmental niche.Age-dependent changes in adult stem
cells are believed to contribute to the
decline in tissue regenerative potential
and function in several organs. Hemato-
poietic stem cells (HSCs) reside primarily
in the bone marrow cavity in incompletely
understood cellular niches where intrinsic
properties of the stem cell and extrinsic
signals from the local microenvironment
cooperatively regulate HSC function.
Paradoxically, in the C57BL/6 mouse
strain, aging results in an expanded HSC
population, as defined functionally and
by phenotypic markers. However, this
quantitatively larger population exhibits
qualitatively different functions, manifest-
ing in a differentiation profile biased
toward myelopoiesis, at the expense
of lymphocyte production, and impaired
bone marrow homing and long-term
engraftment in some transplant regimens
(Harrison et al., 1997; Liang et al., 2005;
Morrison et al., 1996; Sudo et al., 2000).
Numerous cell-intrinsic factors, such as
DNA damage accumulation, chromatin
dysregulation, and oxidative stress, have
been identified as modulators of HSC
aging (Janzen et al., 2006; Rossi et al.,
2005). Until now, however, few studies
have examined the age-associated
changes that occur inmicroenvironmental
niche cells, what causes these changes,
or the effects aged niche cells have on
hematopoietic function. An impediment
to studies addressing these questions
has been the ongoing debate surrounding
the identity of cells comprising the HSC
niche(s). Unlike the carefully delineated
relationship of spermatogonial stem cells
and hub cells in the Drosophila testis, for
example, the relationships between
HSCs and their neighbors in the anatomi-
cally diffuse bone marrow remain murky.
The perivascular and endosteal regions
are two anatomical areas of bone marrowof particular current interest. Both house
a heterogeneous and, in some cases, an
overlapping collection of cells. In aggre-
gate, the cells are thought to regulate
the stem cell microenvironment through
secretion of cytokines and chemokines,
and by adjusting local concentrations of
calcium and perhaps oxygen, in addition
to potential cell-cell interactions.
What initiates the parallel changes
observed in niche cells and HSCs during
development? Howdoes aging alter niche
dynamics? What signals modulate the
number and function of niche cells?
Recently in Nature, Mayack et al. (2010),
address these questions using in vivo
and in vitro parabiosis models and
demonstrate that age-related changes
in supportive hematopoietic niche cells
deregulate normal HSC number and func-
tion (Figure 1). Parabiosis, the natural or
surgical joining of two organisms resulting
in a common circulatory system, is
a model that has been used experimen-
tally since the middle of the 19th century
(Finerty, 1952). The present studies from
the Wagers lab use young and old parabi-
otic partners to study the effects of age on
the sessile stem cell niches and on
blood-borne humoral factors that may
alter stem cell function either directly or
via the niche. Results obtained with
the age-mismatched partners (hetero-
chronic parabionts) were compared to
age-matched partners (isochronic para-
bionts) to obviate effects of parabiosis
itself. Most revealing, however, were
the comparisons between HSCs in the
marrows of individual heterochronic pairs.
The authors found that the number of
HSCs in young isochronic pairs and in
the young partner of heterochronic pairs
was equivalent to the population size
present in unmanipulated young mice.
Thus, exposure to blood from an agedCell Stem Cellpartner did not ‘‘age’’ the HSC population
of the young parabiont. As in unmanipu-
lated old mice, the HSC population was
increased several-fold in old isochronic
parabionts. In contrast, the number of
HSCs in old heterochronic parabionts
was decreased to levels typical of young
animals. Similarly, heterochronic parabi-
osis eliminated the skewed differentiation
profile normally seenwith aged stemcells,
restoring normal ratios of lymphoid and
myeloid cells produced in lethally irradi-
ated recipient mice. These data provide
evidence that a young systemic environ-
ment can restore both the number and
function of aged stem cells to youthful
levels. In addition, the authors used an
existing strategy to isolate osteoblastic
niche cells and assay their impact on
HSC function. Similar to HSCs, the
number of niche cells isolated from the
marrow of aged mice was increased
4-fold compared to young mice. More-
over, brief in vitro exposure to aged osteo-
blastic niche cells expanded HSCs from
youngmarrow. Thus, parabiosis may alter
the age-related changes that normally
occur in niche cells, thereby indirectly
affecting HSC fate and function. Further-
more, the authors found that hetero-
chronic parabiosis restored the number
of agedosteoblastic niche cells to youthful
levels, and this ‘‘rejuvenated’’ popula-
tion was less able to cause HSC accumu-
lation when isolated and tested in vitro.
Together, these studies demonstrate that
both the niche and stem cell populations
aremalleable in terms of size and function.
In order to further investigate mecha-
nisms regulating osteoblastic niche cell
function, Mayack et al. developed an
in vitro model of heterochronic parabiosis
in which niche cells from young mice were
exposed to serum from old mice and vice
versa. After overnight culture with serum,6, February 5, 2010 ª2010 Elsevier Inc. 93
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Figure 1. Heterochronic Parabiosis Rejuvenates HSC Function
In aged mice (top), HSCs accumulate but exhibit skewed patterns of differen-
tiation, favoring more production of myeloid cells at the expense of B lympho-
cytes. This effect is at least partially mediated by osteoblast niche cell produc-
tion of IGF-1. When exposed to soluble factors from young mice (bottom), the
impact of IGF-1 is overcome, HSC accumulation is dampened, and the ratio of
B cell: myeloid cell production is recovered.
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and cocultured with young
HSCs. In accord with the
results in vivo, exposure of
young niche cells to old serum
resulted in HSC accumulation
and, conversely, old niche
cells pretreated with young
serum limited HSC expansion
to near youthful levels. The
authors also pre-exposed
youngnichecells tooldhuman
serum and saw similar results,
suggesting that the unknown
serum factor was conserved
among mammals.
In a final set of experiments,
the authors investigated the
role of insulin-like growth
factor-1 (IGF-1) in niche cell-
HSC interactions. To this end,
young HSCs were cultured
with young or aged niche
cells preincubated with a neu-
tralizing antibody to IGF-1
(a-IGF-1). Pre-exposure of
aged niche cells with a-IGF-1
decreased the accumulation
of HSCs, and similarly in-
hibited young niche cellsexposed to aged serum were also less
able to induce HSC accumulation. In
contrast, IGF-1 neutralization had noeffect
on interactions of HSCs with young niche
cells, with or without pre-exposure to
young serum. The authors also found that
local, but not systemic, IGF-1 neutraliza-
tion via direct injection into the marrow
decreased the ability of aged niche cells
to promote HSC accumulation. Together,
these results suggest that local IGF-1
signaling in aged niche cells impairs their
ability to regulate HSCs and, thus, con-
tributes to age-associated hematopoietic
dysfunction.
The most obvious question raised by
these elegant studies from the Wagers
lab concerns the identity of the factor
present in the circulation that indirectly,
through niche osteoblastic cells, reverses
the aged HSC phenotypes. Themolecular
mechanism by which the unidentified
factor influences the niche appears to
involve IGF-1 signaling without mediating
a direct effect on HSCs. Once the identity
of the factor is uncovered, several other
questions will need to be resolved. For
example, how does it modulate local
IGF-1 levels in the niche? And perhaps94 Cell Stem Cell 6, February 5, 2010 ª2010most importantly, by what molecular
mechanisms do ‘‘age-informed’’ niche
cells convey the message to HSCs?
Reduced IGF-1 signaling has been shown
to enhance longevity by delaying the
effects of aging in simple invertebrate
models aswell as inmammals, suggesting
that signaling through this pathway is
conserved over large evolutionary dis-
tances. Some transgenic models that
exhibit increased life spans also harbor
widespreaddisruptions in IGF-1 signaling,
suggesting that IGF-1 can influence
tissues throughout the organism (Holzen-
berger et al., 2003). While reduced IGF-1
signaling in postmitotic cells may alter
tissue function, it is likely that critical
events leading to loss of tissue homeo-
stasis occur in stem/progenitor cells and
their surrounding niches. Perhaps neutral-
ization of IGF-1 at the source, i.e., stem
cells and their supportive niche cells,
may restore ‘‘youthful’’ signaling in the
stem cell compartment and delay the
aging process.
Heterochronic parabionts have been
used previously to investigate aging in
murine skeletal muscle (Conboy et al.,
2005). Exposure to a young circulatoryElsevier Inc.system ameliorated the age-
impairedmuscle regeneration
normally observed in old
mice. Thus, in muscle as well
as in bone marrow, aging
phenotypes in early progen-
itor cells may be rejuvenated
by circulating factors present
in young animals. Any temp-
tation felt by individuals
approaching their ‘‘golden
years’’ to contemplate re-
ceiving blood transfusions
from young donors is prob-
ably misguided. A more fruit-
ful approach would be to
determine if the serum factor
responsible for the rejuve-
nating effects on skeletal
muscle and bone marrow is
the same, and if so, whether
its impact is more globally
felt, perhaps in the central
nervous system or gut. Identi-
fication of the unknown
factor(s) might then open the
way for pharmaceutical inter-
vention to treat the panoply
of reminders that we are no
longer young.REFERENCES
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